⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19201004 | 1.00 | — | — | |
| SCHEMBL10953408 | 0.91 | NFKB1 (0.41) | — | |
| SCHEMBL22872687 | 0.91 | NFKB1 (0.41) | — | |
| SCHEMBL22267421 | 0.88 | DNM1 (0.44) | — | |
| SCHEMBL20467587 | 0.88 | DNM1 (0.44) | — | |
| SCHEMBL28437674 | 0.88 | NFKB1 (0.35) | — | |
| SCHEMBL830074 | 0.87 | NFKB1 (0.40) | — | |
| Ammonia Solution, Strong SCHEMBL23581245 | 0.84 | NFKB1 (0.38) | — | |
| SCHEMBL31333176 | 0.81 | GABRR1 (0.36) | — | |
| SCHEMBL16297584 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0718260-B1 | Method for working up complex amine hydrofluorides | SOLVAY (BE) | 1998-08-12 | — | — | EP | claimed |
| US-5728884-A | REACTING WITH HALOGENATED ALKENE UNDER CONDITIONS SUCH THAT HYDROGEN FLUORIDE IN THE COMPLEX IS CONSUMED BY ADDITION TO THE HALOGENATED ALKENE | SOLVAY (BE) | 1998-03-17 | — | — | US | claimed |
| EP-3820846-B1 | COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER | ECOLAB USA INC (US) | 2024-01-03 | — | — | EP | disclosed |
| US-20230339866-A1 | Quinazoline compounds and the use thereof in the treatment of cancer | TroBio Therapeutics Pty Ltd (AU) | 2023-10-26 | — | — | US | disclosed |
| US-11180578-B2 | Polymerization inhibitor and retarder compositions with amine stabilizer | ECOLAB USA INC. (US) | 2021-11-23 | — | — | US | disclosed |
| US-20210309634-A1 | COMPOSITIONS AND METHODS FOR TREATING EPIGENETIC DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-10-07 | — | — | US | disclosed |
| US-11123304-B2 | Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210143032-A1 | ATOMIC LAYER ETCH AND DEPOSITION PROCESSING SYSTEMS INCLUDING A LENS CIRCUIT WITH A TELE-CENTRIC LENS, AN OPTICAL BEAM FOLDING ASSEMBLY, OR A POLYGON SCANNER | LAM RESEARCH CORPORATION | 2021-05-13 | — | — | US | disclosed |
| CN-112533902-A | Compositions comprising nitroxide inhibitors, quinone methide blockers and amine stabilizers to inhibit polymerization of monomers | 埃科莱布美国股份有限公司 | 2021-03-19 | — | — | CN | disclosed |
| WO-2021005586-A1 | TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS | NOVARTIS AG (CH) | 2021-01-14 | — | — | WO | disclosed |
| WO-2020081840-A1 | METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS | Magenta Therapeutics Inc. (US) | 2020-04-23 | — | — | WO | disclosed |
| US-20190350870-A1 | Particles as Delivery Systems | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-11-21 | — | — | US | disclosed |
| EP-3246373-B1 | ORGANIC MOLECULES FOR USE AS EMITTERS | CYNORA GMBH (DE) | 2019-01-30 | — | — | EP | disclosed |
| EP-2859962-B1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | MORI KUNIO (JP) | 2019-01-23 | — | — | EP | disclosed |
| EP-3246373-A1 | ORGANIC MOLECULES FOR USE AS EMITTERS | cynora GmbH (DE) | 2017-11-22 | — | — | EP | disclosed |
| US-20140066427-A1 | S1P Receptors Modulators and Their Use Thereof | AKAAL PHARMA PTY LTD. (AU) | 2014-03-06 | — | — | US | disclosed |
| US-5728884-A | REACTING WITH HALOGENATED ALKENE UNDER CONDITIONS SUCH THAT HYDROGEN FLUORIDE IN THE COMPLEX IS CONSUMED BY ADDITION TO THE HALOGENATED ALKENE | SOLVAY (BE) | 1998-03-17 | — | — | US | disclosed |